"Hodgkin Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Descriptor ID |
D006689
|
MeSH Number(s) |
C04.557.386.355 C15.604.515.569.355 C20.683.515.761.355
|
Concept/Terms |
Hodgkin Disease- Hodgkin Disease
- Disease, Hodgkin
- Granuloma, Hodgkin's
- Hodgkin's Granuloma
- Granuloma, Hodgkins
- Hodgkins Granuloma
- Lymphogranuloma, Malignant
- Lymphogranulomas, Malignant
- Malignant Lymphogranuloma
- Malignant Lymphogranulomas
- Hodgkin Lymphoma
- Lymphoma, Hodgkin
- Hodgkin's Disease
- Disease, Hodgkin's
- Hodgkin's Lymphoma
- Hodgkins Lymphoma
- Lymphoma, Hodgkin's
- Hodgkins Disease
- Disease, Hodgkins
- Granuloma, Hodgkin
- Hodgkin Granuloma
- Granuloma, Malignant
- Malignant Granuloma
- Malignant Granulomas
|
Below are MeSH descriptors whose meaning is more general than "Hodgkin Disease".
Below are MeSH descriptors whose meaning is more specific than "Hodgkin Disease".
This graph shows the total number of publications written about "Hodgkin Disease" by people in this website by year, and whether "Hodgkin Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 2 | 0 | 2 |
2017 | 22 | 4 | 26 |
2018 | 35 | 0 | 35 |
2019 | 2 | 2 | 4 |
2020 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hodgkin Disease" by people in Profiles.
-
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021 07 21; 374:n1647.
-
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report. Curr Probl Cancer. 2021 12; 45(6):100739.
-
Paraneoplastic cerebellar degeneration as a presenting manifestation of non-Hodgkin's lymphoma. Neurol Sci. 2021 Jun; 42(6):2523-2525.
-
Resurgence of Covid-19 pandemic: Challenging situation of economics vs. healthcare. Scott Med J. 2021 02; 66(1):1-2.
-
SARS-CoV-2-induced remission of Hodgkin lymphoma. Br J Haematol. 2021 02; 192(3):415.
-
Outcome of a HIV Positive Patient Infected with COVID-19 After an Autologous Bone Marrow Transplantation: A Case Report. Curr HIV Res. 2021; 19(4):377-382.
-
Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient with Hodgkin's Lymphoma History from North of Iran. Infect Disord Drug Targets. 2021; 21(8):e160921191124.
-
Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? J Med Virol. 2021 04; 93(4):1882-1884.
-
COVID-19-induced atypical pulmonary lymphocytes. Blood. 2020 11 05; 136(19):2241.
-
To Transplant or Not to Transplant During the SARS-CoV-2 Pandemic? That Is the Question. Oncologist. 2021 02; 26(2):e336-e337.